Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Malignancy
| Autor: | Amr E. Abbas, Marie Bernardo, Steven W. Werns, Amer N. Kadri, Saba Assar |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Time Factors medicine.medical_treatment 030204 cardiovascular system & hematology Malignancy Transcatheter Aortic Valve Replacement Coronary artery disease 03 medical and health sciences Postoperative Complications 0302 clinical medicine Valve replacement Aortic valve replacement Risk Factors Neoplasms Internal medicine medicine Humans Hospital Mortality 030212 general & internal medicine Heart Valve Prosthesis Implantation business.industry Cardiogenic shock valvular heart disease Aortic Valve Stenosis General Medicine medicine.disease Stenosis Treatment Outcome Aortic Valve Heart failure Cardiology Cardiology and Cardiovascular Medicine business |
| Zdroj: | Cardiovascular Revascularization Medicine. 23:59-65 |
| ISSN: | 1553-8389 |
| Popis: | BACKGROUND Patients with aortic stenosis (AS) and malignancy experience poor clinical outcomes with challenging decisions regarding aortic valve replacement (AVR). We sought to compare the outcomes of transcatheter (TAVR) versus surgical (SAVR) AVR in patients with AS and malignancy. METHODS Based on the Nationwide Readmission Database, we compared all patients with malignancy who underwent isolated SAVR vs. TAVR in 2016 for severe AS. We performed univariate and multivariate analyses for baseline characteristics and clinical outcomes. A total of 2566 patients were included, 1952 (76%) had TAVR and the remaining 614 (24%) had isolated SAVR. Patients who underwent TAVR were older (82 vs 72 years, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect